Continuous Glucose Monitoring Market Growth Supported by Key Drivers, Expected to Hit $16.44 Billion by 2029

 Grab 20% Off With Code ONLINE20 On Global market Reports — Evaluate Global Trends, Market Risks, and Competitive Intelligence

 

 What Are the Key Growth Indicators and Market Expansion Estimates for the Continuous Glucose Monitoring Market Through 2029?
 The continuous glucose monitoring market size has grown rapidly in recent years. It will grow from $8.2 billion in 2024 to $9.44 billion in 2025 at a compound annual growth rate (CAGR) of 15.2%. The growth in the historic period can be attributed to increasing prevalence of diabetes, growing awareness of diabetes management, rising demand for real-time glucose monitoring, increasing adoption of minimally invasive technologies, and rising healthcare expenditure in developed countries.
 
 The continuous glucose monitoring market size is expected to see rapid growth in the next few years. It will grow to $16.45 billion in 2029 at a compound annual growth rate (CAGR) of 14.9%. The growth in the forecast period can be attributed to the increasing shift toward personalized and precision medicine, rising adoption of telehealth and remote patient monitoring, growing focus on preventive healthcare and early diagnosis, growing preference for home-based glucose monitoring, and growing penetration in emerging markets. Major trends in the forecast period include technology miniaturization for implantable devices, developing closed-loop insulin delivery systems, integration into electronic health records, integration with fitness trackers and smartwatches, and innovation in skin-adhesive materials.
 
 Get your free report sample today:
 https://www.thebusinessresearchcompany.com/sample.aspx?id=24512&type=smp
  
 Which Core Market Drivers Are Influencing the Development of the Continuous Glucose Monitoring Market?
 The rising prevalence of diabetes is expected to propel the growth of the continuous glucose monitoring market going forward. Diabetes is a chronic medical condition in which the body either does not produce enough insulin or cannot effectively use the insulin it produces, resulting to high levels of sugar (glucose) in the blood. The rising prevalence of diabetes is primarily due to unhealthy diets high in sugars, fats, and processed foods, which contribute to obesity and impaired insulin function. Continuous glucose monitoring helps diabetes management by providing real-time blood sugar trends, enabling timely decisions on diet, medication, and activity to maintain better glucose control. For instance, in November 2023, according to the American Diabetes Association, a US-based non-profit organization, in 2022, an estimated 25.5 million people in the U.S. were diagnosed with diabetes, representing 7.6% of the total population. This is a 3% increase compared to previous years. Therefore, the rising prevalence of diabetes is driving the growth of the continuous glucose monitoring market.
 
 How Is the Continuous Glucose Monitoring Market Structured Across Its Key Segment Categories?
 The continuous glucose monitoring market covered in this report is segmented — 
 
 1) By Component: Transmitters, Sensors, Receivers
 2) By Age Group: Adults, Children
 3) By End Use: Hospitals, Home Care Settings, Diagnostic Centers And Clinics, Other End Uses
 
 Subsegments:
 
 1) By Transmitters: Reusable Transmitters, Disposable Transmitters, Rechargeable Transmitters
 2) By Sensors: Implantable Sensors, Transcutaneous Sensors, Disposable Sensors, Real-Time Sensors
 3) By Receivers: Standalone Receivers, Integrated Receivers, Wearable Display Devices
 
 Which Major Trends Are Expected to Define the Continuous Glucose Monitoring Market Through 2029?
 Major companies operating in the continuous glucose monitoring market are focusing on developing innovative products such as sensor-based glucose monitors to enhance accuracy, real-time tracking, and patient convenience. Sensor-based glucose monitors are devices that continuously measure blood sugar levels using a small sensor placed under the skin. For instance, in August 2024, DexCom, Inc., a US-based healthcare company, launched Stelo, the first over-the-counter (OTC) continuous glucose monitor (CGM) designed for adults who do not use insulin. Stelo provides real-time, 24/7 glucose readings through a small sensor worn on the back of the upper arm, with data sent directly to a smartphone no prescription or fingersticks needed. The device offers personalized insights and trend analysis, helping users understand how factors like diet, exercise, and sleep impact their glucose levels, enabling smarter lifestyle choices. The sensor lasts up to 15 days, integrates with health apps, and is ideal for people with Type 2 diabetes not on insulin, those with prediabetes, or anyone monitoring their glucose health.
 
 Who Are the Principal Market Leaders in the Continuous Glucose Monitoring Market?
 Major companies operating in the continuous glucose monitoring market are Roche Diabetes Care, Abbott Laboratories, Medtronic plc, Texas Instruments Inc., Microchip Technology Inc., Dexcom Inc., Insulet Corporation, Tandem Diabetes Care Inc., Ypsomed AG, Nova Biomedical, Ascensia Diabetes Care, Zillion Technologies Inc., Bionime Corporation, Biolinq Inc., Beta Bionics Inc., AgaMatrix Inc., A. Menarini Diagnostics S.r.l, Senseonics Holdings Inc., Medtrum Technologies Inc., Nemaura Medical Inc. 
 
 Get the detailed continuous glucose monitoring market report today
 https://www.thebusinessresearchcompany.com/report/continuous-glucose-monitoring-global-market-report
 
 Which Regions Are Expected to Record the Strongest CAGR in the Continuous Glucose Monitoring Market?
 North America was the largest region in the continuous glucose monitoring market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the continuous glucose monitoring market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
 
 Contact Us:
 
 The Business Research Company: https://thebusinessresearchcompany.com/ 
 Americas +1 310–496–7795
 Asia +44 7882 955267 & +91 8897263534
 Europe +44 7882 955267 
 Email: info@tbrc.info 
 
 Follow Us On:
 
 LinkedIn: https://in.linkedin.com/company/the-business-research-company